HIND Stock Analysis: Buy, Sell, or Hold?
HIND - Vyome Holdings, Inc. Common Stock
$2.13
-0.03 (-1.39%)
▼
5d:
-1.84%
30d:
-9.36%
90d:
+0.0%
BUY
HIGH Confidence
Analysis Updated: Jun 29, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When HIND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HIND shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: HIND shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: HIND is currently trading at $2.13, which is considered oversold relative to its 30-day fair value range of $2.14 to $2.29.
Technical Outlook: Technically, HIND is in a downtrend. The price is currently testing key support at $2.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+439.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HIND is in a downtrend. The price is currently testing key support at $2.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+439.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.14 -
$2.29
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 439.9% below Wall St target ($11.50)
Trading Range Analysis
30-Day Trading Range
$2.14 -
$2.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.10
Resistance Level
$2.50
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$11.50
(+439.9%)
Revenue Growth (YoY)
-84.1%
Share & Embed Analysis
Last updated: June 30, 2026 4:05 AM ET
Data refreshes hourly during market hours. Next update: 5:05 AM
Data refreshes hourly during market hours. Next update: 5:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 64 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 67 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 66 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |